Irving-based Biote Corp. an innovator in preventive healthcare through the delivery of personalized hormone therapy, announced Debby Morris has been appointed to its board of directors, bringing more than three decades of experience in directing financial operations and strategy to support high-growth companies.
Biote went public in May through a SPAC deal.
Morris served as the executive vice president and chief financial officer of Apria Inc. from March 2013 through October. Before that, she was chief financial officer-Americas for Sitel Worldwide Corp. from February 2010 to February 2013.
Terry Weber, CEO of Biote
“Debby is an accomplished executive whose deep financial and business expertise—spanning accounting and finance, SEC reporting, internal audit, data analytics, corporate development, and operations—will complement and strengthen our Board. We expect that Debby’s contributions and perspective will prove valuable as Biote continues to execute on our growth strategy,” CEO Terry Weber said in a statement.
Earlier this year, Weber said that Biote has focused on transforming the large and often-overlooked hormone optimization market since the company’s founding. “My generation of women, we suffered silently. We didn’t know who to turn to. Certainly you would never talk about menopause in the workplace. You barely talk about it to your family. You just had a stiff upper lip and got through it,” she said in a Bloomberg story.
Weber adds financial and business experience
Previously, Weber was a partner of Tatum LLC from 2004 to 2010 and as a director from 2008 to 2010. Morris provided interim and permanent chief financial officer services for companies contracted with Tatum LLC including LifeMasters Supported SelfCare and RelaDyne.
Morris serves as a director for Alternative Logistics Technologies, Holdco, LLC, and serves as the chair of the audit committee. She also serves as a director for Rexford Industrial and serves on the audit, compensation, and nomination, and governance committees.
Go here for more DI People news.
You’ll find a roundup of innovators to know in North Texas. DI People includes hires, leadership moves, and accolades. Send us your news here.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
Irving-based Biote, a medical practice-building business within the hormone optimization space, will be listed on Nasdaq through a business combination with Haymaker Acquisition Corp. III. Biote—which will earn projected revenue of $136 million in 2021—trains practitioners to identify and treat early indicators of hormone-related aging conditions. The company then provides components that enable practitioners to establish, build, and successfully operate hormone optimization centers.
-
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Exela Technologies, Newmark, OrangeGrid, RailPros, Aimbridge Hospitality, Integrity Marketing Group, Smoothie King, Bank of Texas, MD7, Salvation Army, and more. Plus, you'll find board appointments including Texas Mutual Insurance, Zimperium, and the Ebby Halliday Foundation.
-
The TechFW board has named its 2022 leadership.
-
It's the first transition of chairs since the organization’s inception. The new chair was announced at the 2022 State of My Possibilities, a virtual event. Plus, Big Thought's Byron Sanders joined My Possibilities' Michael Thomas in a discussion of the importance of creativity and innovation in the charitable sector. Here's a takeaway.
-
It’s the final step in a multi-year transition for the strategic communications firm launched by Gail Cooksey 28 years ago. The agency is “in great hands,” the founder said.
